Patent Expiry

Patent/Exclusivity Expiry: THYQUIDITY

Other upcoming events for MAIA

Phase 3 ReadoutPhase 3 Topline: A Multicenter, Open-label, Randomized Phase 3 Study of THIO Sequenced With Cemiplimab (LIBTAYO®) vs
Patent ExpiryPatent/Exclusivity Expiry: CUBICIN
Patent ExpiryPatent/Exclusivity Expiry: ERMEZA
Patent ExpiryPatent/Exclusivity Expiry: OLPRUVA
Patent ExpiryPatent/Exclusivity Expiry: LEVOTHYROXINE SODIUM

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: THYQUIDITY — MAIA Patent Expiry | BioSniper